Pricing

One subscription. Unlimited analyses.

No tiers based on usage. No limits on tickers. No hidden fees. Begin free, or commit to the practice.

Trial
First analysis on us
Free
  • One full analysis
  • Six-investor verdict
  • PDF export
  • No credit card required
Begin Free
Recommended
Monthly
Most flexible
$39/ month
  • Unlimited analyses
  • Full Buffett-tradition letters
  • PDF export & archive
  • Watchlists & alerts
  • Cancel anytime
Start Monthly
Annual
For the long-horizon investor
$349/ year
Save $119 vs. monthly
  • Everything in Monthly
  • Priority support
  • Early access to new features
  • Quarterly market memos
Start Annual
Compare

What's included.

TrialMonthlyAnnual
Full six-investor analysis✓ 1✓ Unlimited✓ Unlimited
Buffett-tradition letter
20-year scenario projection
PDF export & archive
Watchlists & alerts
Quarterly market memo
Priority support
Early access to new features
30-day money-back guarantee
Frequently Asked

Questions worth asking.

Yes. There is no commitment. You can cancel a monthly subscription at any time and retain access through the end of the billing period. Annual subscribers are covered by the thirty-day money-back guarantee.

Yes. Your first analysis is free. No credit card is required. You will receive a complete six-investor verdict, the Buffett-tradition letter, and a PDF export — the full product on a single ticker.

Monthly subscriptions are billed on a rolling 30-day cycle. Annual subscriptions are billed once per year. We accept all major credit and debit cards through Stripe. We do not store your card information directly.

Not yet. We are focused on the individual analyst — the family-office associate, the portfolio manager, the serious retail investor. Team plans are on the roadmap; if your firm is interested, write to us at hello@amordad.com.

All major credit and debit cards (Visa, Mastercard, American Express, Discover). Apple Pay and Google Pay on supported devices. We do not currently accept cryptocurrency, wire transfer, or invoice billing.

No. AMORDAD is a research and analysis tool. The output is educational. Nothing AMORDAD generates constitutes a recommendation to buy, sell, or hold any security. The decisions are yours; the research is ours.

Your watchlists and analysis history are encrypted at rest. We do not sell your data. We do not share your data with advertisers. We collect only what is necessary to operate the service.

Ready to begin?

Your first analysis is on us.